News
Read the latest news and activity from DRW or sign up to our newsletter
NHS hospitals adopt the next-generation SAMBA to improve patient care
Leading NHS hospitals have adopted the SAMBA III rapid molecular diagnostics platform to transform the way patients with suspected respiratory infections are assessed and managed. “Using SAMBA III will give us greater flexibility meaning that our patients are cared for in the...
29 September 2025
DRW receives CTDA approval for SAMBA III respiratory molecular tests
Diagnostics for the Real World (DRW) is pleased to announce that its SAMBA III SARS-CoV-2 Test and SAMBA III SCoV-2/Flu/RSV Test have received approval under the UK Coronavirus Test Device Approvals (CTDA) process. Following a successful desktop review by the UK’s Medicines and Healthcare...
8 August 2025
The launch of SAMBA III: a new generation of rapid molecular diagnostics
Diagnostics for the Real World (DRW), a pioneer in rapid molecular diagnostics, today announces the launch of the SAMBA III Instrument System – its most advanced point-of-care molecular platform to date. Building on more than two decades of innovation, SAMBA III has...
20 April 2025
Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition
Breakthrough SAMBA II point-of-care diagnostic machine on show to the public from this November, as part of inspiring COVID-19 science showcase.
4 March 2024
Diagnostics for the Real World’s multiplex respiratory virus rapid point-of-care tests approved for sale in New Zealand
SAMBA molecular diagnostic tests deliver fast “one sample, one test” detection of COVID-19, FluA/B and RSV in hospital, laboratory and non-laboratory settings.
4 March 2024
Transformative Role of SAMBA II in Winchester College’s COVID-19 Response
Many congratulations to Dr John Cullerne, Undermaster at Winchester College, whose pioneering work on COVID-19 was recognised recently with an invitation to Buckingham Palace.
4 March 2024
Diagnostics for the Real World (DRW) achieves UK technical validation for two multiplex respiratory virus rapid tests
New combined tests deliver highly accurate point-of-care detection for SARS-CoV-2, Flu A, Flu B and RSV – boosting infection control in hospitals and speeding patient access to urgent care.
4 March 2024
New multiplex tests and next-gen SAMBA platform previewed in 360Dx
Dr Helen Lee and COO Craig Wisniewski talk exclusively about DRW's new multiplex assays, plus the company's plans for the third-generation SAMBA platform.
26 September 2023
Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition
A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.
25 September 2023